Skip to main content
SpringerLink
Log in

Western Diet and Behavior: The Columbus Concept

  • Chapter
  • First Online:
Modern Dietary Fat Intakes in Disease Promotion

Part of the book series: Nutrition and Health ((NH))

Key Points

• Increased intake of refined grains and fast foods is associated with a lower intake of ω-3 fatty acids, vitamins, and antioxidants, and associated with a sequence in the emergence of chronic diseases of affluence.

• Increased consumption of refined carbohydrates may also increase the risk of mental disorders: not only depression, anxiety, stress, personality, and behavioral disorders but also general cognitive impairment in older people.

• Dietary intake of ω-3 fatty acids, antioxidant vitamins A, E, C, and beta-carotene is inversely associated with these psychological disorders.

• There is some evidence that increased intake of linoleic acid, saturated fat, and trans fat as well as refined carbohydrates is proinflammatory, leading to increased plasma levels of transcription factors of proinflammatory cytokines.

• As cytokines may be positively associated with affective and anxiety-related disorders and type A behavior, available clinical trials indicate that treatment with ω-3 fatty acids can modulate depression and behavioral disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The search terms for n – 3 PUFAs (n – 3, omega-3, α-linolenic, eicosapentaenoic, docosahexaenoic, EPA, DHA, ALA, fish, etc.) were combined with terms for mental disorders and psychological function (depression, depressed mood, depressive disorder, affective, cognitive, anxiety, bipolar, personality, etc.).

  2. 2.

    Participants with major depressive disorder who had persistent symptoms of depression in spite of conventional antidepressant pharmaceutical treatment.

References

  1. Popkin BM. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr 2006; 83: 289–298.

    Google Scholar 

  2. Popkin BM. Urbanization, lifestyle changes and the nutrition transition. World Dev 1999; 11: 1905–1916.

    Article  Google Scholar 

  3. Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. Prog Neuro-Psychopharmacol Biol Psychiatry 2007; 31: 12–26.

    Article  CAS  Google Scholar 

  4. Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis 2007; 6: 21.

    Article  PubMed  Google Scholar 

  5. Issa AM, Mojica WA, Morton SC, Traina S, Newberry SJ, Hilton LG, Garland RH, MacLean CH. The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review. Dement Geriatr Cogn Disord 2006; 21: 88–96.

    Article  PubMed  CAS  Google Scholar 

  6. Peet MB, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psych 2003; 59: 913–919.

    Article  Google Scholar 

  7. Behan PO, Behan WMH, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990; 82: 209–216.

    Article  PubMed  CAS  Google Scholar 

  8. Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. Acta Neurol Scand 1999; 99: 112–116.

    Article  PubMed  CAS  Google Scholar 

  9. Stoll AL, Severus WE, Freeman MP et al. Omega-3 fatty acids in bipolar disorder—a preliminary double-blind, placebo-controlled trial. Arch Gen Psych 1999; 56: 407–412.

    Article  CAS  Google Scholar 

  10. Keck PE, Freeman MP, McElroy SL et al. A double-blind placebo controlled trial of eicosapentaenoic acid in rapid cycling bipolar disorder. Bipolar Disord 2002; 4(suppl): 26–27.

    Article  Google Scholar 

  11. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psych 2002; 159: 477–479.

    Article  Google Scholar 

  12. Llorente AM, Jensen CL, Voigt RG et al. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 2003; 188: 1348–1353.

    Article  PubMed  CAS  Google Scholar 

  13. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Seung Kim HF, Puryear LJ. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psych 2003; 160: 996–998.

    Article  Google Scholar 

  14. Su K-P, Huang S-Y, Chiu C-C, Shen WW. Omega-3 fatty acids in major depressive disorder—a preliminary double-blind placebo-controlled trial. Euro Neuropsychopharmacol 2003; 13: 267–271.

    Article  CAS  Google Scholar 

  15. Zanarini MC, Frankenburg MD. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psych 2003; 160: 167–169.

    Article  Google Scholar 

  16. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE et al. An overview of recent findings of the Stanley foundation bipolar network (part I). Bipolar Disord 2003; 5: 310–319.

    Article  PubMed  Google Scholar 

  17. Fux M, Benjamin J, Nemets B. A placebo-controlled cross-over trial of adjunctive EPA in OCD. J Psych Res 2004; 38: 323–325.

    Article  CAS  Google Scholar 

  18. Hirashima F, Parow AM, Stoll AL et al. Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. Am J Psych 2004; 161: 1922–1924.

    Article  Google Scholar 

  19. Silvers KM, Woolley CC, Hamilton FC, Watts PM, Watson RA. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prost Leuk Ess Fatty Acids 2005; 72: 211–218.

    Article  CAS  Google Scholar 

  20. Fontani G, Corradeshi F, Felici A et al. Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 2005; 35: 691–699.

    Article  PubMed  CAS  Google Scholar 

  21. Osher Y, Bersudsky Y, Belmaker RH. Omega-3 eicosapentaenoic acid in bipolar depression: report of small open label study. J Clin Psychiatry 2005; 66: 726–729.

    Article  PubMed  CAS  Google Scholar 

  22. Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006; 113: 31–35.

    Article  PubMed  CAS  Google Scholar 

  23. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 2006; 188: 46–50.

    Article  PubMed  Google Scholar 

  24. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of children’s depression: a controlled, double-blind pilot study. Am J Psychiatry 2006; 163: 1098–1100.

    Article  PubMed  Google Scholar 

  25. Hallahan B, Hibbeln JR, Davis JM, Garland MR. Omega-3 fatty acid supplementation in patients with recurrent self-harm: single-centre double-blind randomised controlled trial. Br J Psychiatry 2007; 190: 118–122.

    Article  PubMed  Google Scholar 

  26. Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA, Ness AR. No effect on n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 2008; 99: 421–431.

    Article  PubMed  CAS  Google Scholar 

  27. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Hoefnagels WH, Beekman ATF, de Groot L. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized double-blind, placebo-controlled trial. Am J Clin Nutr 2008; 88: 706–713.

    PubMed  Google Scholar 

  28. Buydens-Branchey L, Branchey M, Hibbeln JR. Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 568–575.

    Article  PubMed  CAS  Google Scholar 

  29. Lucas M, Asselin G, Merette C, Poulin MJ, Dodin S. Ethyl-eicosapentaenoic acid for treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr 2009; 89: 641–651.

    Article  PubMed  CAS  Google Scholar 

  30. Hamazaki T, Sawazaki S, Itomura M. The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest 1996; 97: 1129–1133.

    Article  PubMed  CAS  Google Scholar 

  31. Kolbe LJ. The application of health behaviour research. Health education and health promotion. In: Gochman DS (ed.), Health Behaviour Emerging Research Perspectives. New York: Plenum Press, 1988.

    Google Scholar 

  32. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Human Behaviour. Englewood Cliffs, NJ: Prentice Hall, 1980.

    Google Scholar 

  33. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975; 13: 10–24.

    Article  PubMed  CAS  Google Scholar 

  34. Condiotte MM, Lichtenstein E. Self-efficacy and relapse in smoking cessation programs. J Consult Clin Psychol 1981; 49: 648–658.

    Article  PubMed  CAS  Google Scholar 

  35. Antonovsky A. Unraveling the Mystery of Health. How People Manage Stress and Stay Well. San Francisco: Jossey Bass, 1987.

    Google Scholar 

  36. Antonovsky A. Rozwikłanie tajemnicy zdrowia. Jak radzić sobie ze stresem i nie zachorować. Warszawa: Wydawnictwo Fundacja IPN, 1995.

    Google Scholar 

  37. Colin A, Reggers J, Castronovo V, Ansseau M. Lipids, depression and suicide. Encephale 2003; 29(1): 49–58.

    PubMed  CAS  Google Scholar 

  38. Delion S, Cahlon S, Guilloteau G et al. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats. J Nutr 1994; 124: 266–276.

    Google Scholar 

  39. Delion S, Cahlon S, Guilloteau G et al. Alpha-linolenic acid deficiency alters age-related changes of dopaminergic and serotonergic neurotransmission in the rat frontal cortex. J Neurochem 1996; 66: 1582–1591.

    Article  PubMed  CAS  Google Scholar 

  40. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995; 62: 1–9.

    PubMed  CAS  Google Scholar 

  41. Yehuda S, Rabinovitz S, Crasso RL, Mostofsky DI. The role of polyunsaturated fatty acids in restoring the aging of neuronal membrane. Neurobiol Ageing 2002; 23: 843–853.

    Article  CAS  Google Scholar 

  42. Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res 1999; 56: 565–570.

    Article  PubMed  CAS  Google Scholar 

  43. Yehuda S. Omega-6/Omega-3 ratio and brain related functions. World Rev Nutr Diet 2003; 92: 37–56.

    Article  PubMed  CAS  Google Scholar 

  44. Jones CR, Arrai T, Rapoport SI. Evidence for the involvement docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurchem Res 1997; 22: 663–670.

    Article  CAS  Google Scholar 

  45. Martin RE, Bazan NG. Changing fatty acid content of growth cone lipids prior to synaptogenesis. J Neurochem 1992; 59: 318–325.

    Article  PubMed  CAS  Google Scholar 

  46. Neuringer M, Reisbick S, Janowsky J. The role of omega-3 fatty acids in visual and cognitive development: Current evidence and methods of assessments. J Pediatr 1994; 125: S39–S47.

    Article  PubMed  CAS  Google Scholar 

  47. Willats P. Long chain polyunsaturated fatty acids improve cognitive development. J Fam Health Care 2002; 12(S6): 5.

    Google Scholar 

  48. Bakker EC, Ghys AJ, Kester AD, Vles JS, Dubas JS, Blanco CE et al. Long-chain polyunsaturated fatty acids at birth and cognitive function ant 7 year of age. Eur J Clin Nutr 2003; 57: 89–95.

    Article  PubMed  CAS  Google Scholar 

  49. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain omega-3 fatty acids during pregnancy and lactation augments children’s IQ at four years of age. Pediatrics 2003; 111: 39–44.

    Article  Google Scholar 

  50. McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005; 82(2): 281–295.

    PubMed  CAS  Google Scholar 

  51. La Guardia M, Giammanco S, Di Majo D, Tabacchi G, Tripoli E, Giammanco M. Omega 3 fatty acids: biological activity and effects on human health. Panminerva Med 2005; 47(4): 245–257.

    PubMed  Google Scholar 

  52. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr 2007; 137: 855–859.

    PubMed  CAS  Google Scholar 

  53. Joseph JA, Shukitt-Hale B, Lau FC. Fruit polyphenols and their effects on neuronal signaling and behavior in senescence. Ann NY Acad Sci 2007; 1100: 470–485.

    Article  PubMed  CAS  Google Scholar 

  54. Salem N Jr, Litman B, Kim HY, Gawrish K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001; 36: 945–959.

    Article  PubMed  CAS  Google Scholar 

  55. Piomelli D. Eicosanoids in synaptic transmission. Crit Rev Neurbiol 1994; 8: 65–83.

    CAS  Google Scholar 

  56. Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003; 48: 195–203.

    PubMed  Google Scholar 

  57. Anderson Gh. Diet, neurotransmitters and brain function. Br Med Bull 1981; 37: 95–100.

    PubMed  CAS  Google Scholar 

  58. Wurtman RJ. Behavioural effects of nutrients. Lancet 1983; 1: 1145–1147.

    Article  PubMed  CAS  Google Scholar 

  59. Singh RB, Niaz MA, Ghosh S, Begom R, Bishnoi I, Agarwal P, Agarwal A. Dietary intake, and plasma levels of antioxidant vitamins in health and disease, case study. J Nutr Environ Med 1995; 5: 235–242.

    Article  CAS  Google Scholar 

  60. Singh R Study of Nutrition, Anxiety, Stress and Behaviour in Relation to Cardiovascular Risk Factors in the Elderly Urban Population of Moradabad, India, Thesis for PhD, Department of Psychology, Gokuldas Girls College, Moradabad, Rohilkhand University, Bareilly, 1998.

    Google Scholar 

  61. Parker G, Gibson NA, Brotchie H, Heruc G, Rees A, Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006; 163: 969–978.

    Article  PubMed  Google Scholar 

  62. Tiemeier H,, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MMB. Vitamin B12, folate, and homocysteine in depression: the Rotterdam study. Am J Psychiatry 2002; 159: 2099–2101.

    Article  PubMed  Google Scholar 

  63. Fabrigoule C, Rouch I, Taberly A, Latenneur CD, Maxaus JM et al. Cognitive process in preclinical phase of dementia. Brain 1998; 121: 135–141.

    Article  PubMed  Google Scholar 

  64. Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry 2000; 12: 159–165.

    PubMed  CAS  Google Scholar 

  65. Hakkarainen R, Partonen T, Haukka J, Albanes D, Lonnqvist J. Is low dietary intake of omega-3 fatty acid associated with depression? Am J Psychiatry 2004; 161: 567–569.

    Article  PubMed  Google Scholar 

  66. Silvers KM, Scott KM. Fish consumption and self physical and mental health status. Public Health Nutr 2002; 5: 427–431.

    Article  PubMed  Google Scholar 

  67. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007; 68(7): 1056–1061.

    Article  PubMed  CAS  Google Scholar 

  68. McIntyre RS, O’Donovan C. Human cost of not achieving full remission in depression. Can J Psychiatry 2004; 49: 10S–16S.

    PubMed  Google Scholar 

  69. Edwards R, Peet M, Shay J, Horrobin D. Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients. Biochem Soc Trans 1998; 26: S142.

    PubMed  CAS  Google Scholar 

  70. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psych 1998; 43: 315–319.

    Article  CAS  Google Scholar 

  71. Tiemeier H, van Tuijl HR, Hoffman A et al. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam study. Am J Clin Nutr 2003; l78: 40–46.

    Google Scholar 

  72. Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D, Ness AR. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 2007; 85(6): 1665–1666.

    Google Scholar 

  73. Tanskanen A, Hibbeln JR, Tuomilehto J. Fish consumption and depressive symptoms in general population in Finland. Psychiatr Serv 2001; 52: 529–531.

    Article  PubMed  CAS  Google Scholar 

  74. Tanskanen A, Hibbeln JR, Hintikka J. Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 2003; 58: 512–513.

    Article  Google Scholar 

  75. Huan M, Hamazaki K, Sun Y, Itomura M, Liu H, Kang W et al. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry 2004; 56: 490–496.

    Article  PubMed  CAS  Google Scholar 

  76. Klerman GL, Weissman MM. Increasing rates of depression. JAMA 1989; 261: 2229–2235.

    Article  PubMed  CAS  Google Scholar 

  77. Hibbeln JR. Fish consumption and major depression. Lancet 1998; 351: 1213.

    Article  PubMed  CAS  Google Scholar 

  78. Hibbeln JR. Seafood consumption, the DHA content of mother’s milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J Affect Disord 2002; 69: 15–29.

    Article  PubMed  CAS  Google Scholar 

  79. Su KP. Mind–body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression. Asia Pac J Clin Nutr. 2008; 17(Suppl 1): 151–157.

    PubMed  CAS  Google Scholar 

  80. Kidd PM. Bipolar disorder as cell membrane dysfunction. Progress toward integrative management. Altern Med Rev 2004; 9(2): 107–135.

    PubMed  Google Scholar 

  81. Werneke U, Turner T, Priebe S. Complementary medicines in psychiatry: review of effectiveness and safety. Br J Psychiatry 2006; 188: 109–201.

    Article  PubMed  Google Scholar 

  82. Morris MC, Evans DA, Tangney CC et al. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005; 62(12): 1849–1853.

    Article  PubMed  Google Scholar 

  83. Moriguchi T, Salem N. Recovery of brain docosahexaenoate leads to recovery spatial performance. J Neurochem 2003; 87: 297–309.

    Article  PubMed  CAS  Google Scholar 

  84. Whalley LJ, Fox HC, Whale KW, Starr JM, Deary IJ. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am J Clin Nutr 2004; 80: 1650–1657.

    PubMed  CAS  Google Scholar 

  85. Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, Fox HC. N-3 fatty acid erythrocyte membrane content, APOE ɛ4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 2008; 87: 449–454.

    PubMed  CAS  Google Scholar 

  86. Nurk E, Drevon CA, Refsum H, Solvoll K, Vollset SE, Nygard O et al. Cognitive performance among the elderly and dietary fish intake: the Hordaland health study. Am J Clin Nutr 2007; 86: 1470–1478.

    PubMed  CAS  Google Scholar 

  87. Dullemeijer C, Durga J, Brouwer IA, van de Rest O, Kok FJ, Brummer RJM et al. N-3 fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr 2007; 86: 1479–1485.

    PubMed  CAS  Google Scholar 

  88. Kokoszka A. Szansa na poprawś skuteczności leczenia schizofrenii i depresji? Przegląd wyników badań suplementacji omega 3 wielonienasyconymi kwasami tłuszczowymi. http://www.termedia.pl/magazine.php?magazine_id=8&article_id=9421&magazine_subpage=FULL_TEXT. 2007.

Download references

Author information

Authors and Affiliations

  1. Institute of Psychology, University of Silesia, ul. Grażyńskiego 53, 40-126, Katowice, Poland

    Agnieszka Wilczyńska-Kwiatek

  2. DMF Ltd Company, Luxembourg Str 46, 6900, Marche/Famenne, Belgium

    Fabien De Meester (Managing Director)

  3. Helberg Research Institute, Moradabad, Uttar Pradesh, India

    Ram B. Singh

  4. Psychological Center PARTNER, Wieczorka 22 Str, Gliwice, Poland

    Łukasz Łapiński

Authors
  1. Agnieszka Wilczyńska-Kwiatek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabien De Meester
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ram B. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Łukasz Łapiński
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Agnieszka Wilczyńska-Kwiatek .

Editor information

Editors and Affiliations

  1. Managing Director, DMF Ltd Company, Luxembourg Str 46, Marche/Famenne, 6900, Belgium

    Fabien De Meester

  2. Mel & Enid Zuckerman College of, Public Health, University of Arizona, Tucson, 85724-5163, Arizona, USA

    Sherma Zibadi

  3. Arizona Health Science Center, Mel and Enid Zuckerman College of Public, University of Arizona, 1501 N. Campbell Ave. Room 4335, Tucson, 85724-5155, Arizona, USA

    Ronald Ross Watson

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Wilczyńska-Kwiatek, A., De Meester, F., Singh, R.B., Łapiński, Ł. (2010). Western Diet and Behavior: The Columbus Concept. In: De Meester, F., Zibadi, S., Watson, R. (eds) Modern Dietary Fat Intakes in Disease Promotion. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-571-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-571-2_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-570-5

  • Online ISBN: 978-1-60327-571-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation